We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
miR-143 inhibits bladder cancer cell proliferation and enhances their sensitivity to gemcitabine by repressing IGF-1R signaling.
- Authors
HENGBING WANG; QI LI; XIAOBING NIU; GONGCHENG WANG; SINIAN ZHENG; GUANGBO FU; ZENGJUN WANG
- Abstract
microRNAs (miRNAs) are a class of small RNAs that regulate gene expression. It has been demonstrated that aberrant miRNA expression is associated with cancer development and carcinogenesis. Altered miRNA expression has been suggested to occur in bladder cancer. In other cancer systems, studies have indicated that miR-143, as a tumor suppressor gene, plays essential roles in cancer progression. However, its role in bladder cancer has yet to be elucidated. In the present study, we observed that miR-143 expression was downregulated in human bladder cancer tissues and cells, and that its levels were negatively correlated with bladder cancer clinical stages. We further demonstrated that insulin-like growth factor-1 receptor (IGF-1R) is a functional target of miR-143. Their expression levels were inversely correlated in bladder cancer samples. Overexpression of miR-143 inhibited cell proliferation and promoted chemosensitivity of bladder cancer 5637 cells to gemcitabine. Consistently, small interfering RNA-mediated knockdown of IGF-1R phenocopied miR-143 overexpression. Notably, the expression of IGF-1R is a predictor of patient prognosis. Collectively, our findings indicate that miR-143 is a valuable biomarker for bladder cancer. The miR-143/IGF-1R axis is associated with bladder cancer drug resistance and patient survival.
- Subjects
BLADDER cancer; CANCER cell proliferation; MICRORNA; SOMATOMEDIN C; CELLULAR signal transduction
- Publication
Oncology Letters, 2017, Vol 13, Issue 1, p435
- ISSN
1792-1074
- Publication type
Article
- DOI
10.3892/ol.2016.5388